Last month, Johnson & Johnson announced that its Janssen Pharmaceutical Companies would further expedite its investigational coronavirus vaccine program through an expanded collaboration with the Biomedical Advanced Research and Development Authority, part of the Department of Health & Human Services’ Office of the Assistant Secretary for Preparedness and Response. CLICK HERE FOR COMPLETE CORONAVIRUS COVERAGEHost Maria Bartiromo noted on Sunday that Johnson & Johnson will be conducting human clinical trials for the COVID-19 vaccine this November. “The most important thing that we can do is stop the virus from occurring in the first place,” Gorsky told Bartiromo. “We expect to be starting up very soon, likely within the next month, and I think we’ll have important data by the end of the year.”He added that in addition to finding a working vaccine, the “other really important component” would be to have an adequate supply. “Right now, we are making very significant investment, somewhat at risk, knowing that we need to have adequate supply in parallel with knowing that the vaccine actually works,” he said.

Source: Fox News March 22, 2020 22:18 UTC